Improving Allergy Immunotherapy Adherence by Branham, Amy
Southern Illinois University Edwardsville
SPARK
Doctor of Nursing Practice Projects School of Nursing
Spring 5-10-2019
Improving Allergy Immunotherapy Adherence
Amy Branham
Follow this and additional works at: https://spark.siue.edu/dnpprojects
Part of the Nursing Commons
This DNP Project is brought to you for free and open access by the School of Nursing at SPARK. It has been accepted for inclusion in Doctor of
Nursing Practice Projects by an authorized administrator of SPARK. For more information, please contact magrase@siue.edu.
Recommended Citation
Branham, Amy, "Improving Allergy Immunotherapy Adherence" (2019). Doctor of Nursing Practice Projects. 59.
https://spark.siue.edu/dnpprojects/59
  
Improving Allergy Immunotherapy Adherence  
Amy Branham, MSN, FNP-BC 
Introduction of the Problem 
Allergic rhinoconjunctivitis is a chronic health issue that affects many people. Its 
prevalence is increasing worldwide.  Consistent with national data regarding allergy 
immunotherapy adherence rates, patients at a suburban Midwest teaching clinic often do not 
complete their full prescribed course of allergy immunotherapy. This can lead to negative effects 
on personal health and overall health system costs. However, there were no plans to improve 
adherence to allergy immunotherapy. 
Literature Review 
Allergic rhinoconjunctivitis (allergic rhinitis) prevalence is increasing worldwide 
(Larsen, Broge, & Jacobi, 2016). This has a direct impact on increasing healthcare costs. The 
costs related to treating allergic rhinitis increased $5.1 billion from 2000-2005 (Koberlein, 
Kothe, Sieber, & Mosges, 2013). Adherence to allergy immunotherapy (AIT) can reduce 
healthcare costs (Larsen et al., 2016). AIT is one of the many treatments available for allergic 
rhinitis. First line treatment for allergic rhinitis is typically over the counter medications (OTC), 
including antihistamines and nasal steroid sprays. AIT is recommended once patients have failed 
treatment with OTC medications. AIT is an effective treatment for allergic rhinitis (Demoly, 
Passalacqua, Pfaar, Sastre, & Wahn, 2016). AIT is cost effective as it reduces over-the- counter 
medication consumption, decreased provider visits, and increased productivity at work and 
school (Larsen et al., 2016). AIT has a disease modifying effect which lasts for several years so 
this further proves it is cost effective.  
  
There are two methods of AIT, these include subcutaneous immunotherapy (SCIT) or 
sublingual immunotherapy (SLIT). SCIT is a subcutaneous injection that is generally given in a 
medical office, and it is the predominant method of AIT. SLIT is available in aqueous drops or 
tablets and is administered at home. Many clinics offer SCIT. SCIT was found to have a higher 
adherence rate (Kiel et al., 2013). However, the adherence rate to the completion of the treatment 
course of AIT is suboptimal at 18% (Kiel et al., 2013). Adherence and completion of the AIT 
course is key to controlling allergic rhinitis symptoms (Senna, Caminati, & Lockey, 2015).  
Adherence to AIT is poor due to the long-term commitment, inconvenient clinic hours, 
lack of transportation, costs, adverse reactions, and several other factors (Senna et al., 2015). The 
most common reason for non-adherence to AIT was inconvenience, regardless of the type of AIT 
(Incorvaia et al., 2008). Four out of ten people were not aware of the long-term commitment 
(Senna et al., 2015). Most patients stop treatment in the first month of AIT (Senna et al., 2015). 
Forty percent of patients expected an absence of allergies and 20% expected reduced symptoms 
days or weeks after starting AIT (Incorvaia et al., 2008).   
A patient’s knowledge of AIT and what to expect is the core of increased adherence to 
treatment (Incorvaia et al., 2008). The more a patient knows about the treatment and what to 
realistically expect can only enhance their adherence to treatment (Demoly et al., 2016). 
Education regarding what allergic rhinitis is, definition of respiratory allergy, what allergen 
immunotherapy is, and how it works has been found to increase adherence to treatment 
(Calderon et al., 2015). A communication template discussing the aforementioned details for 
non-adherent patients found 67% would have resumed AIT after viewing the template (Calderon 
et al., 2015). Effective communication is the key to successful treatment (Senna et al., 2015).  
  
Patients remember about 60% of what is said to them during their initial visit (Senna et 
al., 2015). Redundant education promotes better retention of information and this can increase 
adherence (Senna et al., 2015). Calderon et al’s, (2015) template offers key components of AIT 
and education that can increase adherence to treatment. The template is conducive to printing in 
handouts and other documents that can be revisited by patients. A multi-faceted strategy 
including repeated education, regular follow-up visits, and the use of new technology can be 
successful to increase adherence to AIT (Senna et al., 2015).  
The use of social media and modern technology has the potential to increase adherence to 
AIT (Joshi & Dimov, 2014). A 2012 survey of 3,014 of adults living in the United States found 
85% own a cell phone (Pew Research Center).  Of these cell phone owners, 80% use text 
messaging services, and 9% use text messaging regarding health/medical concerns/appointments 
(Joshi & Dimov, 2014). Text messaging as a daily/weekly reminder for a patient regarding AIT 
can have a positive effect on patient adherence (Joshi & Dimov, 2014). The visual cue acts a 
reminder to the patient. Therefore, it is feasible to implement a text message as a reminder to 
enhance adherence to AIT.  
Project Methods 
The goal of this project was to increase subcutaneous immunotherapy adherence rates by 
focusing on patient education, text message reminders, and clinic accessibility. Initial 
implementation involved working with clinic personnel to develop the content of the reminder 
texts and of additional educational materials. The initial project phase began in May 2018 with a 
meeting with the allergy program director to develop wording/statement for the text message 
reminder and communication/education template, and to discuss the options for increasing the 
hours of allergy clinic. A meeting with information technology (IT) in June 2018 was conducted 
  
to discuss ways to have the text message implemented. The text message included the day of the 
week and time they are scheduled to come in for their allergy injection. Initially, the text 
message was to include the allergy clinic hours, but IT was unable to make this happen due to 
software issues not allowing it. The communication/education template included the definition of 
respiratory allergy, the symptoms and impact of allergic rhinitis, allergy immunotherapy 
benefits, mechanism of action, and anticipated length of treatment. The 
communication/education template was printed with the goal of providing it to patients when 
they came in for their allergy injections, specifically ones who were non-adherent.  At this point 
in time, staffing shortages did not allow for increasing the hours of the allergy clinic. However, 
clinic accessibility improved when the clinic moved to a free-standing building that housed only 
our otolaryngology and allergy clinics. The parking lot is right in front of the building and allows 
patients much easier access to the clinic.  The planned implementation date for the text message 
reminder and teaching materials was June 2018, but this did not occur at that time due to 
administrative issues.  However, the changes were executed at the beginning of fall.  The text 
message reminders, which included appointment day and time, were sent to patients who receive 
subcutaneous immunotherapy and who had agreed to receive the text.  The 
communication/education template was given to patients each time they came in for their 
injection beginning in September 2018.  
To evaluate effectiveness, a convenience sample of individuals receiving subcutaneous 
immunotherapy was collected over a 3-month period during the months of September through 
December 2018.  The adherence rate was measured prior to implementation of the text message 
reminder and communication/education template. It was then measured again once the project 
was completed.  Prior to implementation and collection, an IRB was submitted.  The Southern 
  
Illinois University Edwardsville IRB determined that this effort was considered a Quality 
Improvement Project (QIP) and did not constitute human subjects research as defined under 
45CFR 46.102(l).  Therefore, no further action was required prior to starting the implementation. 
 
Evaluation 
There were 172 SCIT patients at the clinic.  Thirty-nine percent of SCIT patients were 
non-adherent to AIT prior to the implementation of this project. Adherence was defined as 
patients who routinely come to receive their scheduled injections. Non-adherence was defined as 
patients who regularly skip/miss their scheduled injections.  During the project, 2 patients moved 
out of state, 2 patients had their insurance change and could no longer come to the clinic, and 12 
patients dropped out completely. Fourteen of the remaining 51 non-adherent patients became 
adherent to AIT as a result of this project. The non-adherence rate went from 39% to 27%. 
One week after the project completed a 4-point Likert scale survey was given to patients 
to gauge their satisfaction with the text message reminders. Twenty-four surveys were completed 
of which 19 indicated they would like the text message reminder to continue. Comments on the 
surveys seemed to indicate the texts were helpful in reminding patients to come for their 
injections. The text message reminders were being sent 6 days prior to the patient’s scheduled 
injection appointment. Of the 19 who wished to continue the text message reminders, they 
indicated they would prefer receiving the texts 1-2 days prior to their scheduled injection 
appointment. Clinic accessibility was enhanced when the clinic moved locations. However, the 




Impact on Practice 
Multiple practice improvements were achieved with implementation of this DNP project. 
Adherence to AIT improved as a result of the text message reminders and 
communication/education template. Patients seemed satisfied with receiving reminders to help 
them adhere to their allergy injection regimen. Patients voiced the communication/education 
template was helpful and informative.  
Future plans include meeting with IT to evaluate the possibility of sending the text 
message reminders 1-2 days prior to the scheduled injection appointment. This would be more 
helpful and a better reminder for the patients. We anticipate that the long-term impact will 
include healthier patients and reduced health care costs. This project can be replicated if the 
clinic’s EHR/business software has the capability to send appointment reminders. The 
communication/education template can be replicated/reproduced.  
Conclusion 
Allergic rhinitis is a chronic but treatable health issue. Allergic rhinitis contributes to 
increased health care costs and decreased productivity at work and school. AIT is an effective 
disease modifying treatment for allergic rhinitis with long-term results. AIT adherence is key in 
order to achieve the lasting effects. AIT adherence can be improved with text message reminders 
and communication/education templates. Engaging patients with multiple cues can successfully 
increase adherence to treatment. Increasing adherence to AIT is worth a shot and will decrease 
the ever-growing health care costs.  
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